NASDAQ: FENC FENNEC PHARMACEUTICALS INC. 8-K

Fennec Pharmaceuticals announces four PEDMARK abstracts accepted at 2026 ASCO conference

Filed April 22, 2026 · Period ending April 22, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade FENC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 1:15 AM